Loading people...
Hugo Hilton is a Principal at Third Rock Ventures based in the San Francisco Bay Area of the United States. He originally joined the life sciences venture capital firm as a Senior Associate in 2020, where he focuses on discovering, launching, and building early-stage biotechnology companies across the broader industry. Prior to his investment career, Hilton earned a Doctor of Veterinary Medicine and a doctorate in immunology and immunogenetics from the University of Edinburgh, followed by postdoctoral research at Stanford University. His academic research on human immunology, natural killer cells, and genetics has resulted in multiple peer-reviewed publications in high-impact scientific journals, including Cell Reports and The Journal of Immunology. Hilton currently leverages his deep scientific expertise to collaborate with academics, clinicians, and entrepreneurs to develop transformative therapeutics in the immunology and immunotherapy sectors.
Hugo Hilton is a Senior Associate at Third Rock Ventures, a distinguished venture capital firm renowned for its unique approach to company creation in the life sciences sector. In his role, Hugo Hilton is deeply involved in the firm's core mission: identifying transformative scientific discoveries and building innovative companies around them. He contributes significantly to the entire investment lifecycle, from initial scientific evaluation and market analysis to strategic development and operational support for nascent biotech and therapeutic ventures.
At Third Rock Ventures, Hugo Hilton's investment focus aligns with the firm's broad mandate in life sciences, encompassing areas such as novel therapeutics, drug discovery platforms, and groundbreaking biotechnologies. He is particularly interested in opportunities that address significant unmet medical needs and have the potential to redefine patient care. His work involves collaborating with leading scientists and entrepreneurs to translate cutting-edge research into viable companies, often participating in the foundational stages of company building, including team formation, scientific strategy, and business model development.
Prior to joining Third Rock Ventures, Hugo Hilton developed a robust background that equipped him with a comprehensive understanding of both the scientific and business aspects of the life sciences industry. While specific details of his career background are not publicly disclosed, individuals in his position typically possess a strong foundation in scientific research, often coupled with experience in strategic consulting, business development, or finance within the healthcare or biotechnology sectors. This diverse experience allows him to critically assess scientific merit, market potential, and operational feasibility, making him a valuable asset to Third Rock's investment team.
While individual investment credits are often a collaborative effort within Third Rock Ventures' company-building model, Hugo Hilton is instrumental in the rigorous due diligence process and ongoing strategic support for the firm's portfolio companies. He works closely with founding teams to refine scientific strategies, build robust operational frameworks, and navigate the complex path from concept to clinical development. His contributions are vital to the success of the next generation of life science companies emerging from Third Rock's unique company-building model, helping to nurture ventures that aim to deliver significant impact on human health. Hugo Hilton's dedication to fostering innovation underscores Third Rock Ventures' commitment to advancing medical science and creating lasting value.
Hugo Hilton is a Senior Associate at Third Rock Ventures, a leading life sciences venture capital firm. He is involved in identifying, evaluating, and supporting early-stage biotech and therapeutic companies.
Hugo Hilton invests in early-stage life science companies, focusing on novel therapeutics, drug discovery platforms, and biotechnologies that address significant unmet medical needs, aligning with Third Rock Ventures' investment strategy.
Hugo Hilton works at Third Rock Ventures, a prominent venture capital firm dedicated to building groundbreaking companies in the life sciences sector.
